 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Your "Missile-Guided Weapon" Attack Against Pancreatic Cancer
Miami (SPX) May 20, 2004 CyberKnife Center of Miami today announced it will begin treating patients with pancreatic cancer, after clinical trials at Stanford University showed CyberKnife's robotic, image-guided system of delivering radiation would benefit most patients. Using a robotic arm and missile guidance technology, CyberKnife delivers targeted doses of radiation to often inoperable tumors with sub-millimeter accuracy. The center in Miami, the only one in the Southeast United States, treats tumors and cancer in the brain, spine, lungs, liver breast, head, neck and now pancreas. Treatment is covered by major insurance carriers and costs 20 to 45 percent less than conventional surgery. "The Stanford study is important because the present alternatives for locally advanced pancreatic cancer leave a lot to be desired," said Dr. Mark Perman, a Miami radiation oncologist trained to use the CyberKnife. "Using conventional radiation therapy at full dose is not always well tolerated. Patients frequently experience unpleasant side effects. Because the CyberKnife is able to target lesions more precisely, we avoid some of these temporary symptoms, control the growth of the tumor and relieve the pain associated with pancreatic cancer quickly." Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States. Each year approximately 30,000 people are diagnosed. The normal treatment for this often inoperable tumor is external radiation and chemotherapy, delivered over weeks to months. Most patients die by the end of the first year, and less than five percent survive five years. In the Stanford study, all patients successfully tolerated their robotic radiation treatment, delivered in a single day. Practically no toxicity was encountered. The clinical trials were so successful that protocols for lower radiation dosages were discontinued so that all patients in the study could benefit from the optimum dosage with the CyberKnife. More than 7,000 patients worldwide have been treated by the CyberKnife stereotactic radiosurgery system at 16 centers worldwide. Developed by a Stanford University neurosurgeon, it is the only robotic image-guided radiation system that enables the precise targeting and treatment of tumors anywhere in the body. The CyberKnife Center of Miami is an independent, free-standing center and is open to select community physicians who have been trained and credentialed in CyberKnife radiosurgery. Community Email This Article Comment On This Article Related Links CyberKnife SpaceDaily Search SpaceDaily Subscribe To SpaceDaily Express Space Medicine Technology and Systems
Genomic Sequences Processed In Minutes, Rather Than Weeks
Richland WA (SPX) Jun 22, 2005A new computational tool developed at the Department of Energy's Pacific Northwest National Laboratory is speeding up our understanding of the machinery of life - bringing us one step closer to curing diseases, finding safer ways to clean the environment and protecting the country against biological threats. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
